Market Place
Sourcing Support
Microbion Reports Positive Phase 2 Data for Diabetic Foot Ulcers
13 Nov 2024 //
PR NEWSWIRE
Microbion Pravibismane Ph 1b DFU Published in International Wound Journal
04 Apr 2024 //
PR NEWSWIRE
Microbion Presented Pravibismane Data Against Mycobacteroides abscessus
15 Aug 2023 //
PR NEWSWIRE
Microbion Granted US Patent for Use of Inhaled Pravibismane
04 Apr 2023 //
PR NEWSWIRE
Microbion Initiates Phase 2 Clinical Study Evaluating Topical Pravibismane
09 Mar 2023 //
PR NEWSWIRE
Microbion Highlights Pravibismane Activity Against Cystic Fibrosis
03 Nov 2022 //
PRNEWSWIRE
Microbion Announces Granting of US Patent for Pharma Composition of Pravibismane
04 Oct 2022 //
PRNEWSWIRE
Microbion Corporation Receives up to $2.1M in Funding
07 Jun 2022 //
PRNEWSWIRE
Microbion Corp Announces Data Highlighting In Vitro Activity of Pravibismane
01 Jun 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.